Estrogen causes rapid endothelial nitric oxide (NO) production because of the activation of plasma membrane-associated estrogen receptors (ER) coupled to endothelial NO synthase (eNOS). In the present study, we determined the role of G proteins in eNOS activation by estrogen. Estradiol-17␤ (E 2 , 10 ؊8 M) and acetylcholine (10 ؊5 M) caused comparable increases in NOS activity (15 min) in intact endothelial cells that were fully blocked by pertussis toxin (Ptox). In addition, exogenous guanosine 5-O-(2-thiodiphosphate) inhibited E 2 -mediated eNOS stimulation in isolated endothelial plasma membranes, and Ptox prevented enzyme activation by E 2 in COS-7 cells expressing ER␣ and eNOS. Coimmunoprecipitation studies of plasma membranes from COS-7 cells transfected with ER␣ and specific G␣ proteins demonstrated E 2 -stimulated interaction between ER␣ and G␣ i but not between ER␣ and either G␣ q or G␣ s ; the observed ER␣-G␣ i interaction was blocked by the ER antagonist ICI 182,780 and by Ptox. E 2 -stimulated ER␣-G␣ i interaction was also demonstrable in endothelial cell plasma membranes. Cotransfection of G␣ i into COS-7 cells expressing ER␣ and eNOS yielded a 3-fold increase in E 2 -mediated eNOS stimulation, whereas cotransfection with a protein regulator of G protein signaling, RGS4, inhibited the E 2 response. These findings indicate that eNOS stimulation by E 2 requires plasma membrane ER␣ coupling to G␣ i and that activated G␣ i mediates the requisite downstream signaling events. Thus, novel G protein coupling enables a subpopulation of ER␣ to initiate signal transduction at the cell surface. Similar mechanisms may underly the nongenomic actions of other steroid hormones.
The hormone estrogen classically exerts its effects by modifying gene expression through the action of estrogen receptors that serve as transcription factors (1) . There are also important nongenomic actions of estrogen in a variety of tissues including bone, mammary gland, pituitary gland, neuron, ovary, and vasculature (2) (3) (4) (5) . We and others have previously shown that estrogen acutely stimulates the endothelial isoform of nitric oxide synthase (eNOS) 1 by mechanisms that are nongenomic yet mediated by estrogen receptor ␣ (ER␣) (6 -8) .
Recent studies demonstrate that there is a subpopulation of ER␣ localized to the endothelial cell plasma membrane in caveolae, where it functions in a signaling module with eNOS (9) . Involvement of the tyrosine kinase-MAP kinase signaling pathway has been implicated in the mechanism of ER-mediated eNOS activation (8) , and very recent work supports a role for the recruitment of the PI3-kinase-Akt pathway that may entail direct interaction between ER␣ and the p85 subunit of PI3-kinase (10, 11) . However, the mechanisms by which plasma membrane ER␣ initiate signaling events remain unresolved (12) . The best-described agonists for eNOS, acetylcholine and bradykinin, activate specific plasma membrane-associated G protein-coupled receptors (GPCR) (13, 14) . G proteins are heterotrimers of ␣, ␤, and ␥ subunits (G␣␤␥), which dissociate into G␣ and G␤␥ upon GPCR stimulation, and activated G␣ and/or G␤␥ then modulate the activity of downstream effector molecules. Based on sequence and functional similarities, the ␣ subunits are divided into four subfamilies: G␣ s , G␣ i , G␣ q , and G␣ 12/13 (15, 16) . To better understand the mechanisms responsible for nongenomic ER␣ action in endothelial cells, the present investigation was designed to delineate the role of G proteins in eNOS stimulation by estrogen. Studies were performed in both an immortalized endothelial cell line and in transfected COS-7 cells expressing ER␣ and eNOS to test the hypothesis that G proteins are required for coupling of plasma membrane ER␣ to eNOS. Additional experiments were designed to assess potential interactions between plasma membrane ER␣ and G␣ proteins and to determine whether downstream signaling leading to eNOS stimulation is mediated by activated G␣ or G␤␥ .
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection-Immortalized ovine fetal pulmonary artery endothelial cells were propagated as previously described and studied at near confluence at passage 15-27 (17) . The capacity of estrogen to activate eNOS observed in the endothelial cells was replicated in COS-7 cells transfected with human ER␣ cDNA and bovine eNOS cDNA using LipofectAMINE Plus (Life Technologies, Inc.), as previously outlined (8) ; COS-7 cells do not constitutively express ER or eNOS (9, 18) . Additional experiments were done in COS-7 cells in three different paradigms: 1) cotransfection with cDNAs for ER␣ and G␣ i2 , G␣ q , or G␣ s, 2) cotransfection with ER␣ and eNOS cDNAs and empty vector, G␣ i1 , or G␣ i2 cDNA (19) , or 3) cotransfection with cDNAs for expression of eNOS and ER␣ and either empty vector or cDNA for a negative regulator of heterotrimeric G protein-mediated signal transduction (RGS), RGS4 (20) . The G␣ cDNAs were presented in pCMV5, and RGS4 was presented in pCB6. Transfection efficiency assessed by immunofluorescence staining was ϳ20%, and coexpression was evident in the majority of transfected cells.
Western Blot Analysis-The methods used for Western blot analysis generally followed those previously reported (9) . ER␣ and eNOS protein abundance was determined in transfected COS-7 cell lysates with a 1:100 dilution of mouse monoclonal antibody to human ER␣ (AER 320, Neomarkers, Inc., Fremont, CA) or a 1:2,000 dilution of polyclonal antiserum to human eNOS kindly provided by Dr. Thomas Michel (Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA). Additional Western blots were performed with rabbit polyclonal antibodies to G␣ i1 and G␣ i2 (B084, 1:12,000), G␣ q (W082, 1:2,500), or G␣ s (584, 1:10,000) (21) (22) (23) . Antiserum W082 was generously provided by Dr. Paul Sternweis (Department of Pharmacology, University of Texas Southwestern Medical Center).
NOS Activation-NOS activation was assessed in whole cells by measuring [ 3 H]-L-arginine conversion to [ 3 H]-L-citrulline using previously reported methods (6) . The capacity of estrogen to stimulate eNOS was evaluated in incubations done in the presence of 10 Ϫ8 M estradiol-17␤ (E 2 ). eNOS activation by the known agonist acetylcholine (10 Ϫ5 M) or the calcium ionophore A23187 (10 Ϫ5 M) was also examined. Under all conditions employed, the [ 3 H]-L-citrulline generation was fully inhibited by 2 mM nitro-L-arginine methyl ester. In selected studies, cells were preincubated with either phosphate-buffered saline alone (control) or phosphate-buffered saline containing 100 ng/ml pertussis toxin (Sigma) for 120 min, and eNOS activation was determined in the continued absence or presence of pertussis toxin (24) . Basal NOS activity was not altered by pertussis toxin. In individual experiments, a minimum of three wells was used for each treatment group. All findings were confirmed in at least three independent studies.
Additional experiments were performed in highly purified plasma membranes isolated from endothelial cells by Percoll gradient (18, 25) . We have recently demonstrated ER-mediated activation of eNOS and the presence of ER␣ protein in isolated endothelial cell plasma membranes. Using previously described methods, eNOS activation by 10 Ϫ8 M E 2 was assessed in the membranes during 30-min incubations with or without 2 mM GDP␤S or GTP (Sigma) or purified GTP␥S added (9, 26) .
Coimmunoprecipitation-The methods employed for coimmunoprecipitation were similar to those previously used by others in studies of epidermal growth factor and platelet-derived growth factor receptors (27, 28) . COS-7 cells transfected with ER␣ and G␣ i , G␣ q , or G␣ s cDNA 48 h earlier were treated with vehicle or 10
Ϫ8 M E 2 for 20 min and homogenized with a Dounce apparatus in ice-cold 0.25 M sucrose buffer containing 1 mM EDTA and 20 mM Tricine, pH 7.8. Aliquots of whole cell lysate were saved, the plasma membrane fraction was isolated (9) , and 400 g of plasma membrane was dissolved by dilution in an equal volume of buffer (final concentrations: 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1 mM EDTA). The plasma membrane samples were precleared with protein A/G Plusagarose beads (Calbiochem, San Diego, CA) for 60 min before the addition of either 10 l (2 g) of monoclonal anti-ER␣ antibody (AER 320) or 1 l of polyclonal anti-G␣ i (P960) (29) and incubated at 4°C overnight. The plasma membranes were further incubated for 2 h in the presence of 25 l of protein A/G Plus-agarose beads at 4°C, and the beads were washed four times with buffer (25 mM Tris-HCl, pH 7.5, 5 mM EDTA, 150 mM NaCl, 1% Triton X-100). The beads were subsequently pelleted, and immunoprecipitates were eluted by boiling for 3 min in SDS sample buffer and separated by SDS-polyacrylamide gel electrophoresis. Protein transfer and Western blot analyses for ER␣ and G␣ were done using the methods described above. Similar studies were done with plasma membranes isolated from endothelial cells previously treated with vehicle or 10
Ϫ8 M E 2 for 20 min. In additional experiments, transfected COS-7 cells were treated with 10
Ϫ8 M E 2 in the absence or presence of the ER antagonist ICI 182,780 (10 Ϫ5 M) or with 10
Ϫ8 M E 2 in the absence or presence of 100 ng/ml pertussis toxin for 120 min prior to plasma membrane isolation. All findings were replicated in three independent experiments.
Statistical Analysis-Comparisons between two groups were made using Student's t test, and comparisons between more than two groups employed Student's t tests with Bonferroni correction for multiple comparisons. Nonparametric analysis was employed when indicated. Significance was accepted at the 0.05 level of probability.
RESULTS
Role of G Proteins-To evaluate the potential role of G proteins in E 2 -stimulated eNOS activity, intact endothelial cells were pretreated with vehicle or pertussis toxin and exposed to either the known GPCR agonist acetylcholine (10 Ϫ5 M) or E 2 (10 Ϫ8 M) for 15 min (Fig. 1A) . In the absence of pertussis toxin, acetylcholine and E 2 caused comparable NOS stimulation, as previously observed (9, 17) . eNOS activation by acetylcholine was fully blocked by pertussis toxin. Similarly, eNOS stimulation by E 2 was prevented by pertussis toxin treatment. In contrast, pertussis toxin did not prevent eNOS activation by the calcium ionophore A23187 (data not shown). To further define the role of G proteins in E 2 -stimulated eNOS activation by an independent means, the effect of exogenous GDP␤S on eNOS stimulation by E 2 was evaluated in isolated endothelial cell plasma membranes (Fig. 1B) . When membranes were exposed to E 2 alone, eNOS was activated, as previously observed (9) . However, when GDP␤S was added, eNOS stimulation by E 2 was inhibited by 70%. E 2 -stimulated eNOS activity was not affected by GTP or GTP␥S (data not shown). The plasma membrane preparations presumably contained sufficient endogenous GTP, the predominant guanine nucleotide in cells, to yield ER-and G protein-mediated eNOS activation that could not be further stimulated by additional GTP or GTP␤␥S.
To confirm the observations made in endothelial cells and to provide a model system amenable to manipulation by cotransfection, the process was reconstituted in COS-7 cells, which do not constitutively express either ER or eNOS. The effect of pertussis toxin on E 2 -stimulated NOS activity in COS-7 cells transfected with eNOS and ER␣ is shown in Fig. 1C . E 2 treatment (10 Ϫ8 M for 15 min) caused eNOS stimulation that was completely blocked by pertussis toxin. Cells transfected with eNOS alone were not responsive to E 2 (data not shown).
Plasma Membrane ER␣-G␣ Interactions-Potential interactions between plasma membrane ER␣ and G␣ proteins were first evaluated in coimmunoprecipitation studies using COS-7 cells transfected with ER␣ and G␣ i2 , G␣ q , or G␣ s ( Fig. 2A) . Forty-eight h following transfection, immunoprecipitation was performed with ER␣ antibody on plasma membranes from cells treated with vehicle or 10
Ϫ8 M E 2 for 20 min. Equivalent expression of transfected ER␣ and G␣ proteins between study groups was confirmed by Western blot analysis of whole cell lysates. In plasma membranes from quiescent cells, G␣ i , G␣ q , and G␣ s were minimally coimmunoprecipitated with ER␣. However, the association of G␣ i with ER␣ was markedly greater following E 2 stimulation. In contrast, the association of G␣ q and G␣ s with ER␣ remained negligible after E 2 treatment.
To determine whether interactions occur between plasma membrane ER␣ and G␣ i when the proteins are expressed at endogenous levels, additional studies were performed in endothelial cells (Fig. 2B) . In plasma membranes from quiescent cells there was minimal G␣ i coimmunoprecipitated with ER␣. In contrast, interaction between ER␣ and G␣ i was readily detectable in plasma membranes from endothelial cells treated with 10
Ϫ8 M E 2 for 20 min. The requirement for ER activation in the induction of interaction between ER␣ and G␣ i was tested in transfected COS-7 cells (Fig. 3A) . Forty-eight h following transfection, immunoprecipitation with ER␣ antibody was done on plasma membranes from cells treated with vehicle, 10
Ϫ8 M E 2 , or E 2 plus 10 Ϫ5 M ICI 182,780 for 20 min. The abundance of ER␣ and G␣ i protein on the plasma membrane was comparable in the different treatment groups. As observed in Fig. 2A , there was minimal interaction between the two proteins in plasma membrane from quiescent cells, and the interaction was enhanced by E 2 treatment. In contrast, ER␣-G␣ i interaction stimulated by E 2 was prevented by ICI 182,780.
The extreme C terminus of G␣ subunits is involved in the interaction of G␣ with classical GPCR (30) , and pertussis toxin inhibits the function of most G␣ i subfamily members by causing ADP ribosylation of a conserved cysteine at the fourth position (24) . To determine whether the G␣ C terminus is similarly involved in the interaction of G␣ with ER␣, the effects of pertussis toxin on ER␣-G␣ i coimmunoprecipitation were evaluated in plasma membranes from transfected COS-7 cells. Forty-eight h following transfection, immunoprecipitation was performed with ER␣ antibody on plasma membranes from cells treated with vehicle, 10
Ϫ8 M E 2 , or E 2 after pertussis toxin pretreatment (Fig. 3B) . ER␣ and G␣ i protein abundance on the plasma membrane was similar in the various study groups. As observed in Figs. 2A and 3A , there was minimal interaction between the two proteins in plasma membrane from quiescent cells, and the interaction was enhanced by E 2 treatment. In contrast, ER␣-G␣ i interaction stimulated by E 2 was prevented by pertussis toxin. Identical findings were obtained in parallel experiments in which immunoprecipitation was done with antibody to G␣ i (Fig. 3C) ; the interaction between ER␣ and G␣ i that was enhanced by E 2 was prevented by pertussis toxin.
Mediation of Downstream Signaling-Upon stimulation of classical GPCR, either the activated G␣ or G␤␥ subunits modulate the activity of downstream effectors (30) . The potential role of activated G␣ i in acute eNOS stimulation by E 2 was evaluated by cotransfection of either sham vector or G␣ i2 cDNA in COS-7 cells expressing ER␣ and eNOS. Whereas basal eNOS activity was unchanged by cotransfection with G␣ i2 , G␣ i2 overexpression augmented E 2 -mediated eNOS stimulation 3-fold, and pertussis toxin completely blocked the enhanced response
FIG. 2. Interaction of plasma membrane ER␣ and G␣ proteins.
A, coimmunoprecipitation of ER␣ and G␣ i , G␣ q , or G␣ s in COS-7 cell plasma membranes. Cells were transfected with ER␣ and G␣ i , G␣ q , or G␣ s cDNAs, and 48 h later cells were treated with vehicle or 10
Ϫ8 M E 2 for 20 min. Plasma membranes were isolated, and immunoprecipitation (IP) was done with ER␣ antibody. Western blot (WB) analyses were performed on whole cell lysates and plasma membrane immunoprecipitates for ER␣ and G␣ i , G␣ q , or G␣ s . The band below the ER␣ or G␣ band in the IP samples is IgG heavy chain. B, coimmunoprecipitation of ER␣ and G␣ i in endothelial cell plasma membranes. Near-confluent endothelial cells were treated with vehicle or 10 Ϫ8 M E 2 for 20 min, plasma membranes were isolated, and immunoprecipitation was done with ER␣ antibody. Western blot analyses were performed on immunoprecipitates for ER␣ and G␣ i . Results shown are representative of three independent experiments. (Fig. 4A ). G␣ i1 overexpression had similar effects (data not shown).
The role of activated, endogenous G␣ i was further substantiated in experiments assessing the effect of a negative regulator of heterotrimeric G protein-mediated signal transduction, or RGS. RGS4 is known to attenuate signaling by accelerating the GTPase activity of members of the G␣ i and G␣ q subfamilies but not that of G␣ s or G␣ 12/13 (31) . eNOS activation by E 2 was evaluated in COS-7 cells expressing ER␣ and eNOS that were cotransfected with either sham vector or RGS4 cDNA (Fig. 4B) . In cells overexpressing RGS4, estrogen-mediated eNOS stimulation was decreased by 90%.
DISCUSSION
Nongenomic actions of estrogen on vascular cells play a significant role in the cardioprotective properties of the hormone (32) . In an effort to elucidate the underlying mechanisms, we and others have previously shown that estrogen acutely stimulates NO production in endothelium and that this is due to the activation of plasma membrane-associated ER␣, leading to eNOS stimulation (6, 9, 33) . In the present study, we employed a variety of approaches to show that plasma membrane ER␣ are coupled to eNOS via G proteins. This includes experiments demonstrating that plasma membrane ER␣ protein interacts with G␣ i protein in endothelial cells. To our knowledge, this is the first evidence in any cell type that steroid hormone receptor proteins interact with G proteins.
All known GPCR have seven transmembrane-spanning domains linked by alternating intracellular and extracellular loops. Extensive experimentation indicates that the GPCR intracellular domains function in the signal propagation to G␣␤␥ (15, 34) . Because the structure of ER␣ is entirely different from any known GPCR, it is unlikely that ER␣-G␣ i interaction is direct. Alternatively, ER␣ may be coupled to a classical GPCR that interacts directly with G␣ i . There is recent evidence that cross-talk of this type can occur to enable non-GPCR to perform G protein-mediated functions, such as the direct protein-protein coupling of ␥-aminobutyric acid, type A receptors to dopamine D5 receptors in hippocampal neurons. The cross-talk involves specific domains on both the non-GPCR undergoing ligand activation and the GPCR interacting with G protein (35) . Detailed mutagenesis and yeast two-hybrid studies are now warranted to identify the domain(s) of ER␣ and the potential intermediary protein(s) required for ER␣ interaction with G␣ i .
We present multiple lines of converging evidence that indicate that G␣ i mediates estrogen stimulation of eNOS. Whereas inhibition of the signaling event in isolated plasma membranes with GDP␤S implicates any G protein isoform, attenuation by RGS4 in the COS-7 cell system narrows the field down to the G␣ i or G␣ q subfamilies (20, 31) . The inhibition of ER-mediated eNOS activation by pertussis toxin implicates G␣ i subfamily members only, of which G␣ i is expressed in endothelial cells, whereas G␣ o is not (16, 24, 30) . The role of G␣ i is further supported by the demonstration of an interaction between ER␣ and G␣ i proteins in plasma membranes from transfected COS-7 cells that is dependent on ER␣ ligand binding, and by confirmation of this interaction in membranes from endothelial cells. In addition, the augmentation in signaling between ER␣ and eNOS with overexpression of G␣ i in the COS-7 cell system not only confirms the proximal role of G␣ i but also indicates that it is the ␣ subunit, rather than G␤␥, that transmits the signal downstream to the effector. Our findings differ from those of a previous report in which membranes from Chinese hamster ovary cells overexpressing ER demonstrated increased binding of GTP␥S to G␣ s and G␣ q upon activation by E 2 (36) . However, the latter studies were performed in a different cell type, they were limited to an overexpression paradigm, and G protein function and interaction with ER were not evaluated.
The extreme C terminus of G␣ subunits are involved in the interaction of G␣ with classical GPCR (30) . To determine whether the G␣ i C terminus plays a similar role in the interaction of G␣ i with ER␣, the effect of pertussis toxin on ER␣-G␣ i coimmunoprecipitation was evaluated in plasma membranes from transfected COS-7 cells. Pertussis toxin, which inhibits G␣ function by causing ADP ribosylation of a conserved cysteine at the fourth position (24) , prevented the coimmunoprecipitation of G␣ i with ER␣ antisera that is induced by E 2 stimulation. In a parallel manner, the coimmunoprecipitation of ER␣ with G␣ i antisera was enhanced after E 2 stimulation, Ϫ8 M E 2, or E 2 plus 10 Ϫ5 M ICI 182,780 for 20 min. Plasma membranes were isolated, and immunoprecipitation (IP) was done with ER␣ antibody. Western blot (WB) analyses for ER␣ and G␣ i were performed on immunoprecipitated plasma membranes or on whole plasma membranes to assess protein abundance. B and C, similarly transfected COS-7 cells were treated for 20 min with vehicle alone, 10
Ϫ8 M E 2, or E 2 after pretreatment with 100 ng/ml pertussis toxin (PT) for 120 min. Plasma membranes were isolated, and immunoprecipitation was done with either ER␣ antibody (B) or G␣ i antibody (C), followed by Western blot analysis. Results shown are representative of three independent experiments. and it was blunted by pertussis toxin. Thus, it is likely that the C terminus of G␣ i is involved in ER␣-G␣ i interaction.
In previous experiments, we showed that eNOS activation by E 2 is prevented by tyrosine kinase or MAP kinase kinase inhibition and that the hormone causes MAP kinase activation in endothelial cells (8) . These observations are consistent with ER-mediated MAP kinase activation reported in other cells (3, 37) , and they suggest that tyrosine kinase-MAP kinase signaling plays a role in ER-mediated stimulation of eNOS. More recently, other laboratories have provided evidence that the activation of the enzyme by E 2 involves the PI3-kinase-Akt pathway. This includes studies demonstrating a direct interaction of ER␣ with the p85 regulatory subunit of PI3-kinase (10, 11) . However, it remains unclear whether ER␣-p85 binding occurs in vivo and whether this interaction leads to the activation of PI3-kinase. Furthermore, the possibility that additional signaling molecules may be required to activate the PI3-kinase complex remains unexplored (12) . The present study suggests that G␣ i activation is proximal to the multiple signaling events that occur upon estrogen binding to ER␣ in the plasma membrane and the stimulation of eNOS that follows. Further experimentation is now indicated to determine the processes immediately downstream of ER␣ activation of G␣ i , to define the kinetics of activation of the tyrosine kinase-MAP kinase and PI3-kinase-Akt pathways by ER␣, and to understand the relative importance of these pathways in eNOS activation in vitro and in vivo (12) . In addition to explaining the proximal signaling events mediating the nongenomic effects of estrogen in endothelial cells, the present observations provide further support of a role for G proteins in nongenomic actions of estrogen in other cell types such as osteoblasts and neurons (4, 38) . There is also accumulating evidence that certain nongenomic actions of progesterone, glucocorticoids, vitamin D3, and testosterone involve steroid hormone receptors acting through pertussis toxin-sensitive mechanisms (39 -43) . It is anticipated that future studies of the processes by which plasma membrane ER␣ are coupled to G␣ i in endothelial cells will provide valuable new information not only about the basis of nongenomic estrogen action in vascular and nonvascular cells but also about the means by which other steroid hormones have important nonnuclear effects.
